In The News

Covidien Announces $2.8 Billion Acquisition of ev3

Practices: Mergers & Acquisitions, Life Sciences, Securities & Public Companies Industries: Biotechnology & Pharmaceuticals

Ropes & Gray is representing Covidien plc in its $2.8 billion acquisition of ev3, Inc., a provider of treatments for peripheral vascular and neurovascular diseases, announced on June 1. Representation includes securities and public companies partner Paul Kinsella.

Cookie Settings